Harrow Health Inc expected to post a loss of 12 cents a share - Earnings Preview

Harrow

21/03/2023 21:05

* Harrow Health Inc  HROW.OQ   HROW.O  is expected to show a
rise
in quarterly revenue when it reports  results on March 23. 
    * The Nashville Tennessee-based  company is expected to
report  a
6.0% increase in revenue to $21.402 million from $20.19 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Harrow Health Inc
is for
a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Harrow
Health Inc
is $19.25​, above​ its last closing price of $18.03. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.01       0.00       -0.24     Missed  -9,500
 Jun. 30 2022  -0.03       -0.01      -0.23     Missed  -3,348
                                                        .3
 Mar. 31 2022  -0.03       -0.03      0.03      Beat    185.7​
 Dec. 31 2021  -0.04       -0.04      -0.27     Missed  -535.3
 ​​Sep.        -0.02       -0.02      -0.31     Missed  -1,140
 30 2021                                                
 Jun. 30 2021  -0.03       -0.03      -0.09     Missed  -200​
 Mar. 31 2021  -0.04       -0.03      0.01      Beat    128.6
 Dec. 31 2020  0.05        0.04       0.04      Met     14.3
 This summary was machine generated March 21 at 21:05 GMT.  All
figures in US dollars  unless otherwise stated